Details
Stereochemistry | MIXED |
Molecular Formula | C20H27N3O6 |
Molecular Weight | 405.4449 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCOCC(CN1C(=O)NC(=O)C(CC)(C1=O)C2=CC=CC=C2)OC(N)=O
InChI
InChIKey=QHZQILHUJDRDAI-UHFFFAOYSA-N
InChI=1S/C20H27N3O6/c1-3-5-11-28-13-15(29-18(21)26)12-23-17(25)20(4-2,16(24)22-19(23)27)14-9-7-6-8-10-14/h6-10,15H,3-5,11-13H2,1-2H3,(H2,21,26)(H,22,24,27)
Molecular Formula | C20H27N3O6 |
Molecular Weight | 405.4449 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Febarbamate is a derivative of barbituric acid and carbamate, used for the treatment of generalized anxiety and alcohol withdrawal syndrome. The drug was marketed in Europe in the 1980s as a single agent or in combination with difebarbamate and phenobarbital, but it was later withdrawn from the market because of the potential risk of liver damage.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:29:19 GMT 2023
by
admin
on
Fri Dec 15 16:29:19 GMT 2023
|
Record UNII |
5Z48ONN38P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QM03BA05
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
||
|
WHO-ATC |
M03BA05
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
||
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1135
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
C65626
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
13246-02-1
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
100000081786
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
24807
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | RxNorm | ||
|
5Z48ONN38P
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
1243
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
FEBARBAMATE
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
236-226-3
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
m1153
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID40864380
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
C003087
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104283
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
25803
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
SUB07519MIG
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY | |||
|
DB13303
Created by
admin on Fri Dec 15 16:29:19 GMT 2023 , Edited by admin on Fri Dec 15 16:29:19 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |